Bionow | News

New NHC Service launched to accelerate gene therapy development

Sep 26th 2024

The National Horizons Centre at Teesside University has launched VecTUs, a new research-grade BioVector production service.

Biocair takes home two awards at the prestigious Asia-Pacific Cell & Gene Therap...

Sep 22nd 2023

Biocair, a distinguished life science logistics company with over three decades of expertise, was announced as the winner of two awards at the esteemed Asia-Pacific Cell & Gene Therapy Excel...

Celebrating 20 years at Biocair: An interview with Christopher Good

Aug 24th 2023

Christopher Good, Director of Cell and Gene Therapy Logistics at Biocair, reflects on his last two decades with the company and how the industry has changed during that time.

BIomatics to support Cell and Gene Therapy Catapult to accelerate programme of O...

Aug 9th 2023

Business transformation consultancy Biomatics is to work alongside innovation and technology organisation, the Cell and Gene Therapy Catapult.

Biocair develops dedicated team for cell and gene therapy logistics

Dec 5th 2022

Biocair has invested heavily in the creation of a specialist logistics team to meet the complex needs of the rapidly expanding cell and gene therapy sector.

UK Supplier expands to provide Chemically Defined & Serum-Free Cell Media Soluti...

Nov 15th 2022

BioPharma Dynamics, a leading life sciences solution provider, proudly expand their extensive portfolio for the Cell & Gene Therapy market to offer a range of chemically defined T-Cell Media...

Oncology & Precision Medicine: bringing together cancer prevention and cutting-e...

Oct 27th 2022

For the first time in 2022, the Oncology & Precision Medicine Conferences were a two-day event with 120 delegates coming together to discuss the current oncology landscape and the future of ...

PeproTech Cytokine Production Facility

Jul 30th 2021

PeproTech announces 65,000 square foot expanded production facility in a multimillion dollar investment

Catalent Supports Belgium-Based Cell and Gene Therapy Accelerator

Jul 5th 2021

Brussels South Charleroi BioPark (BSCB) recently announced it has launched a Cell and Gene Therapy Accelerator program to de-risk early stage research and create the advanced therapy compani...

Infex appoints Lonza to manufacture new lung infection drug

May 14th 2021

Infex Therapeutics has awarded a £1m contract to Lonza to help progress its RESP-X program, a novel therapy which targets serious recurrent respiratory infections in patients with damaged l...

BioPharma Dynamics present their comprehensive process solutions for the Cell an...

Mar 17th 2021

Curating their extensive portfolio of process solutions to serve a multitude of cell therapy applications, BioPharma Dynamics are utilising their infrastructure and industry experience, to s...

Atelerix Strengthens Its Leadership Team

Jun 26th 2020

Atelerix welcomes Steve Docksey as Executive Chair and Ed Wagena as Chief Operating Officer! Atelerix has significantly strengthened its leadership team with two experienced industry execut...

News